Published October 17, 2025 By Lynn Nonnemaker, Ph.D., Josh Jorgensen, Maddie News See full article HERE The past several years have been active in the policy space for Medicare Advantage…
By Ben Frank, Unity HealthTech Prior authorization has always been a pain point in oncology, but for proton therapy, the stakes feel even higher. Decisions made by payers affect…
The National Association for Proton Therapy is pleased to share this curated guide to proton therapy-related presentations at the 2025 ASTRO Annual Meeting in San Francisco. This resource highlights key…
On the Hill In March, NAPT met with key Congressional offices and committee staff to advocate for policies that protect and expand access to proton therapy. Discussions focused on improving…
As we follow the actions of the new presidential administration and await more announcements about healthcare leadership and cancer research initiatives, it’s a good time to reflect on the past…
NAPT Advocacy Report: 2024 Throughout 2024, the National Association for Proton Therapy (NAPT) continued to amplify its advocacy efforts and health policy initiatives. These efforts aligned with NAPT’s mission to…
Congressional Updates Medicare Payment Rules Released The Centers for Medicare & Medicaid Services (CMS) recently released 2025 proposed Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (OPPS)…
Congressional Updates Doc Fix Signed Into Law A “mini-bus” federal funding package signed into law March 9 included the “Doctor Fix,” mitigating Medicare physician payment cuts by 1.68% effective March…
NAPT NEWS For Immediate Release: January 18, 2024 – The National Association for Proton Therapy (NAPT), the nation’s leading organization dedicated to increasing patient access to one of the most…
Cancer is a disease where the passage of time can make a difference in treatment outcomes. Recent research underscores the reality that for cancer patients, each week of delay in…
